1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Cadila Pharma launches affordable drugs for lung cancer – Newstrack India

November 22, 2013Lungadmin

Newstrack India

Cadila Pharma launches affordable drugs for lung cancer
Newstrack India
According to company sources, Mycidac-C is an innovative research product for patients suffering from a cancer sub-type - non-small cell lung cancer. It has been said that the Drug Controller General of India has approved the drug for launch in India.

Post navigation

← Research and Markets: Congestive Heart Failure (Heart Failure) – Pipeline … – The Herald | HeraldOnline.com (press release) Obama Signs Law Allowing Organ Donation Between HIV-Positive Patients – Towleroad →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos